The Efficacy and Safety of Thymosin Alpha 1 for Sepsis: a Multicenter , Double-Blinded, Randomized and Controlled Clinical Trial
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Thymalfasin (Primary)
- Indications Sepsis
- Focus Adverse reactions; Therapeutic Use
- Acronyms TESTS
- 26 Sep 2016 According to a SciClone Pharmaceuticals media release, the company anticipates completing enrollment in the trial in 2018, with data potentially available in 2019. A positive outcome in this Phase III trial could lead to inclusion of ZADAXIN in the China Sepsis Treatment Guidelines.
- 26 Sep 2016 According to a SciClone Pharmaceuticals media release, first patient has been treated in the study.
- 26 Sep 2016 Status changed from not yet recruiting to recruiting, according to a SciClone Pharmaceuticals media release.